#384 – Special episode — Obicetrapib: The CETP inhibitor with cardiovascular benefits and potential Alzheimer’s prevention (opens in new tab)

"It's hard for me to mask my personal optimism around this. I love the biological plausibility of this, and I think that obicetrapib has done something that it's four predecessors has failed to do." —Peter Attia The post #384 – Special episode — Obicetrapib: The CETP inhibitor with cardiovascular benefits and potential Alzheimer’s prevention appeared first on Peter Attia.